GOLIVER THERAPEUTICS
Created in 2017
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,347Activities
Technologies
Entity types
Location
8 Quai Moncousu, 44000 Nantes, France
Nantes
France
Employees
Scale: 2-10
Estimated: 32
SIREN
789683190Engaged corporates
5
1 5Added in Motherbase
1 year, 1 month ago
deeptech Value proposition
Repair the liver without graft
GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation.
GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures.
ACCUEIL - Goliver Therapeutics - Développement de Médicaments
Goliver Therapeutics est une spin-off de CRTI UMR1064, ITUN, CHU de Nantes, spécialisée dans le développement de Médicaments de Thérapie Innovantes (MTI).
https://golivertx.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Région Pays de la Loire National and local authorities, Government Administration | Région Pays de la Loire National and local authorities, Government Administration | Other 26 Mar 2024 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 26 Mar 2024 | | |
 SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 26 Mar 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 26 Mar 2024 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 1 Apr 2024 | | |